Literature DB >> 9179464

Progression of normal glucose tolerance to impaired glucose tolerance or diabetes in the elderly.

L Hiltunen1, S L Kivelä, E Läärä, S Keinänen-Kiukaanniemi.   

Abstract

Factors predicting impared glucose tolerance (IGT) and diabetes (DM) were studied in a community-living population aged 70 years or over, with initial normal glucose tolerance (NGT). The baseline examinations from 1991 to 1992 included an oral glucose tolerance test (OGTT), physical examinations and questionnaires. The follow-up examinations in 1994 and 1995 comprised of an OGTT. One hundred and thirteen of the eligible 134 subjects, with baseline NGT, participated in the re-examinations. Thirty six percent of these subjects progressed to IGT and 3% to DM. Obesity was the best predictor of IGT or DM, and central obesity was also associated with them. In addition, abnormal progression of glucose tolerance was also associated with those aged greater than 80 years, with systolic blood pressure greater than 160 mmHg, diastolic blood pressure greater than 80 mmHg, fasting blood glucose value of greater than 5.3 mmol/l, and 2 h of blood glucose value greater than 6.8 mmol/l.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9179464     DOI: 10.1016/s0168-8227(96)01379-4

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  2 in total

1.  Fasting tests of insulin secretion and sensitivity predict future prediabetes in Japanese with normal glucose tolerance.

Authors:  Yukiko Onishi; Tomoshige Hayashi; Kyoko Kogawa Sato; Takehide Ogihara; Nobuaki Kuzuya; Motonobu Anai; Katsunori Tsukuda; Edward J Boyko; Wilfred Y Fujimoto; Masatoshi Kikuchi
Journal:  J Diabetes Investig       Date:  2010-10-19       Impact factor: 4.232

2.  Cluster Analysis of Unhealthy Lifestyles among Elderly Adults with Prediabetes: A Cross-Sectional Study in Rural China.

Authors:  Xiaofen Wang; Hailiang Gao; Huilan Xu
Journal:  Diabetes Ther       Date:  2019-08-13       Impact factor: 2.945

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.